International Stem Cell (ISCO) Gross Margin (2010 - 2026)

International Stem Cell (ISCO) has reported Gross Margin for 17 consecutive years, with 54.5% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin fell 761.0% year-over-year to 54.5% in Q2 2026; TTM through Jun 2026 was 55.86%, a 194.0% decrease from a year earlier, with the FY2025 full-year figure at 55.68%, down 289.0% from the prior year.
• Gross Margin was 54.5% for Q2 2026 at International Stem Cell, up from 50.53% in the prior quarter.
• Over five years, Gross Margin peaked at 64.58% in Q2 2022 and troughed at 50.53% in Q4 2025.
• A 5-year average of 58.13% and a median of 59.48% in 2022 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin jumped 659 bps in 2022 and sank 899 bps in 2025, its largest moves.
• Over 5 years, Gross Margin stood at 53.25% in 2022, then gained by 2 bps to 54.31% in 2023, then climbed by 10 bps to 59.53% in 2024, then decreased by 15 bps to 50.53% in 2025, then rose by 8 bps to 54.5% in 2026.
• The last three Gross Margin figures came in at 54.5% (Q2 2026), 50.53% (Q4 2025), and 55.76% (Q3 2025), per Business Quant data.